--(BUSINESS WIRE)--Hope Biosciences Stem Cell Research Foundation, administered through the Greater Houston Community Foundation, was founded to address the need to accelerate translational research in regenerative medicine so that therapies could be delivered to patients faster. The foundation is designed to not just support promising trials but to help develop innovative protocols using the latest technology to ultimately deliver high-quality data for quicker approvals. Today, the foundation is leading the effort in using mesenchymal stem cells to combat COVID-19, with three FDA authorized protocols for coronavirus. Current active protocols also include Cerebral Palsy, Parkinson’s Disease, Spinal Cord Injury, Traumatic Brain Injury, Alzheimer’s Disease, ALS and Severe Osteoarthritis. For more information, please visit https://www.hopebio.org/.
Company: |
Hope Biosciences Stem Cell Research Foundation |
|
|
|
|
Headquarters Address: |
16700 Creekbend Dr |
|
|
Sugar Land, TX 77478 |
|
|
|
|
Main Telephone: |
346-900-0340 |
|
|
|
|
Website: |
||
|
|
|
Type of Organization: |
Non-profit |
|
|
|
|
Industry: |
Research & Science |
|
|
|
|
Key Executives: |
President: Donna Chang |
|
|
|
|
Public Relations |
|
|
Contact: |
Jan Shultis |
|
Phone: |
346-900-0340 |
|
Email: |
